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Abstract
The respiratory tract with its ease of access, vast surface area and dense network of anti-
gen-presenting cells (APCs) represents an ideal target for immune-modulation. Bio-
mimetic nanocarriers such as virosomes may provide immunomodulatory properties to
treat diseases such as allergic asthma. In our study we employed a triple co-culture model
of epithelial cells, macrophages and dendritic cells to simulate the human airway barrier.
The epithelial cell line 16HBE was grown on inserts and supplemented with human blood
monocyte-derived macrophages (MDMs) and dendritic cells (MDDCs) for exposure to influ-
enza virosomes and liposomes. Additionally, primary human nasal epithelial cells (PHNEC)
and EpCAM+ epithelial progenitor cell mono-cultures were utilized to simulate epithelium
from large and smaller airways, respectively. To assess particle uptake and phenotype
change, cell cultures were analyzed by flow cytometry and pro-inflammatory cytokine con-
centrations were measured by ELISA. All cell types internalized virosomes more efficiently
than liposomes in both mono- and co-cultures. APCs like MDMs and MDDCs showed the
highest uptake capacity. Virosome and liposome treatment caused a moderate degree of
activation in MDDCs from mono-cultures and induced an increased cytokine production in
co-cultures. In epithelial cells, virosome uptake was increased compared to liposomes in
both mono- and co-cultures with EpCAM+ epithelial progenitor cells showing highest uptake
capacity. In conclusion, all cell types successfully internalized both nanocarriers with viro-
somes being taken up by a higher proportion of cells and at a higher rate inducing limited
activation of MDDCs. Thus virosomes may represent ideal carrier antigen systems to
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modulate mucosal immune responses in the respiratory tract without causing excessive
inflammatory changes.
Introduction
With its ease of access, the vast surface area and extended network of dendritic cells (DCs), the
respiratory tract represents a promising target for inhaled immune-modulatory approaches by
bio-mimetic nanocarriers such as virosomes and liposomes [1]. Ongoing exposure to environ-
mental air and inhaled antigens represents a continuous challenge to the immune system [1].
Epithelial cells with tight junctions, DCs,macrophages, surfactant film and the muco-ciliary
escalator together constitute a structural and functional barrier to protect the respiratory sys-
tem against harmful pathogens [2].
DCs are the most effective antigen-presenting cells (APCs) found in the respiratory tract
that capture, process and present antigens [3,4]. DCsmaintain lung homeostasis by orchestrat-
ing host responses to benign and harmful foreign substances, making them suitable targets for
immunotherapeutic approaches [4]. DCs have the ability to migrate to draining lymph nodes
where they stimulate antigen specific proliferation of naïve T-lymphocytes and their differenti-
ation into effector T cells [5]. This provides an important role in allergic airway diseases such
as allergic asthma, which is frequently characterized by a skewed Th2 cell response.
Besides DCs, other APCs are present in the respiratory tract including B cells and macro-
phages [6,7]. Macrophages are scavenger cells that phagocytose particulate antigens and patho-
gens [8]. Recruitment of macrophages to the site of inflammation can induce both, positive
feedback by producing pro-inflammatory cytokines such as IL-1β and tumor necrosis factor
alpha (TNF-α) recruiting T cells by chemokine production, or negative feedback by secreting
IL-6 and nitric oxide (NO) which dampen DC development and maturation [9]. Depending on
the way macrophages are activated, these cells can behave in different ways [10]. The so-called
conventional macrophage type 1 phenotype (M1) is activated by IFN-γ or danger signals such
as LPS and is characterized as pro-inflammatory. Moreover, it is involved in pathogen killing
and plays a role in chronic inflammatory states. Conventional macrophage type 2 phenotype
(M2) is alternatively activated by IL-4 and/or IL-13 and is known to have anti-inflammatory
properties. In addition, it plays a role in tissue repair, promotes immunoregulation and con-
structive tissue remodelling[11][12][13]. However, there is no unique definition of M1 or M2
macrophages as clarified in Murray et al [12], therefore we will state how we polarizedmacro-
phages and hence call themM1 (IFN-γ and LPS induced) or M2 (IL-4 induced).
Airway epithelial cells (AECs) provide not only barrier function but also play an important
role in maintenance of pulmonary homeostasis [14]. Given the close proximity of AECs to air-
way mucosal dendritic cells (AMDCs) and alveolar macrophages, it is not surprising that AECs
regulate innate and adaptive immunity in the lung. AECs modulate the function of immune
responsive cells, such as AMDCs, by expressing different surface molecules and secreting cyto-
kines [15,16]. Direct and indirect interactions betweenAECs and AMDCs seem to play an
important role in allergic airway diseases such as allergic asthma, as both contribute to sensiti-
zation, initiation and progression of chronic disease [15]. Activated AECs secrete Th2-trophic
cytokines such as IL-25 and IL-33 which condition DCs to produce IL-5 and IL-13, and thereby
favour Th2 polarization [15,17].
Bio-mimetic antigen nanocarriers such as virosomes or liposomes are promising com-
pounds for inhaled, non-invasive, and specifically tailored immune-modulation. Influenza
virosomes and liposomes are spherical vesicles, comprised of lipids and close to 100 nm in
Immune Effects of Liposomes and Virosomes in a Co-Culture Model of the Lung
PLOS ONE | DOI:10.1371/journal.pone.0163539 September 29, 2016 2 / 25
entity with a financial interest. MA is employed by
Mymetics SA, which provided support in the form
of salary to MA and specific research materials for
the preparation of nanoparticles, but did not have
any additional role in the study design, data
collection and analysis, decision to publish, or
preparation of the manuscript. The specific roles of
MA are articulated in the "author contributions"
section.
diameter. Not only do virosomes provide carrier function by incorporating or encapsulating
antigens, but they additionally are potent immune stimulators due to influenza virus envelope
proteins integrated in the membrane [18,19]. Also, influenza virosomes provide high safety
and excellent tolerability due to absence of genetic material and their purity, having already
been approved for human use in prophylactic applications [20–22] and tested clinically in vari-
ous diagnostic and therapeutic approaches[23].
The aim of this study was to establish a human model of the respiratory tract to study the
interplay between epithelial cells, macrophages, and DCs, as well as interactions with bio-
mimetic nanocarriers such as liposomes and virosomes to closely represent the human situa-
tion in vitro and therefore reduce animal experimentation to a minimum. To achieve this, we
optimized a triple co-culturemodel integrating a human bronchial epithelial cell line (16HBE),
monocyte-derivedmacrophages (MDMs) and monocyte-derivedDCs (MDDCs)[24]. In addi-
tion, uptake and immune effects of influenza virosomes or liposomes were tested with in vitro
differentiated primary human nasal epithelial cells (PHNEC) and EpCAM+ epithelial progeni-
tor cell mono-cultures representing cells of the larger and smaller airways, respectively which
are key players of the pulmonary innate immune system to inhaled pathogens.
Material and Methods
Atto647-PE Conjugation
The fluorchrome Atto647N NHS ester (1.7 μmol in DMSO; Sigma) was conjugated to 8.5 μmol
OPPE (1-Oleoyl-3-palmitoyl-rac-glycero-2-phosphoethanolamine; Bachem, Bubendorf, Swit-
zerland) in 90 mM dodecyl octaethylene glycol ether (OEG; Sigma)-PBS pH 7.4.
Virosome and Liposome Formulation
Influenza virosomes were prepared as follows. In short: per ml of final formulation, 8 mg of
DOPC (1,2-dioleoyl-sn-glycero-3-phosphocholine;Merck, Darmstadt, Germany) and 1 mg of
OPPE were dissolved in 100 mMOEG in PBS pH 7.4 (52.7 mM phosphate, 82 mMNaCl).
Inactivated influenza A/Brisbane/59/2007H1N1 virus was mixed with PBS and centrifuged at
100.000xg for 1h at 18°C. The pellet of inactivated influenza virus was resuspendedwith 100
mMOEG-PBS pH 7.4 for 10 min followed by sonication for 1 min at 30°C. This mixture was
centrifuged at 100.000xg for 1h at 18°C to pellet down the nucleocapsid complex. The superna-
tant containing the solubilized influenzamembrane proteins and lipids was used for virosome
formulation and mixed with phospholipids at a concentration of 0.2 mg/ml hemagglutinin
(HA). Virosome formation took place after removal of OEG detergent using 0.375 g per ml of
formulation of SM2 Bio-Beads (BioRad) twice for 1h and once for 30 min at room temperature
whilst mixing at 100 rpm. Fluorescent virosomes were obtained by adding Atto647-PE as indi-
cated prior to detergent removal to enable peptide incorporation. Liposomes were prepared
similarly by leaving out the influenza virus component but following the same procedure. At
the end of the process virosomes and liposomes were sterile filtered on 0.22 μm units (Millex-
GP; Merck Millipore).
Characterization of Virosome and Liposome Formulations
Nanocarriers were thoroughly characterized prior to use. Particle size, homogeneity, as well as
the amount of HA were analyzed. Size determinationwas performed in PBS pH 7.4 by dynamic
light scattering (DLS) using a ZetasizerNano S instrument and by nanoparticle tracking analy-
sis (NTA) on a NanoSight NS300 instrument (both fromMalvern Instruments, Malvern, UK).
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Samples were routinely measured for endotoxin by performing limulus amebocyte lysate
(LAL) test.
Influenza HA concentration of virosomes was determined by SDS-PAGE using a 4–20%
precast mini-protean TGX gel (BioRad) and Coomassie Brilliant Blue R-250 (BioRad) staining
with a One-Color Protein MolecularWeight Marker (Odyssey, LiCor). HA concentration was
confirmed by Spotblots and Western Blots using nitrocellulose (0.2 μm pore size; Life Technol-
ogies) and rabbit anti-HA and rabbit anti-OVA serum followed by secondary goat-anti-rabbit
IRDye 800CW (LiCor Biosciences), visualized and quantified using the LiCorOdyssey imaging
system (Lincoln, Nebraska, USA). Selected samples were also quantified in a SRID (single
radial immunodiffusion) assay to confirm the HA concentration.
Human Monocyte-Derived DC Cultures
Cells were obtained from buffy coats of healthy individuals provided by blood donors from the
Regional Red Cross BloodDonation Centre (Bern, Switzerland). Peripheral bloodmononu-
clear cells (PBMCs) were obtained by Pancoll density centrifugation and monocytes were iso-
lated by CD14 positive selection using MACS microbeads (Miltenyi Biotec GmbH, Bergisch
Gladbach, Germany). MDDCs were generated by culturing in RPMI 1640 medium (Invitro-
gen) supplemented with 10% fetal calf serum (FCS), 1% L-glutamine (2 mM, Invitrogen), 1%
penicillin/streptomycin (100 U/ml, Invitrogen), 10 ng/ml GM-CSF (R&D Systems) and 10 ng/
ml IL-4 (R&D Systems) for 7 days at 37°C/5%CO2.
Human Monocyte-Derived Macrophage Cultures
Cells were obtained from buffy coats of healthy individuals provided by blood donors from the
Regional Red Cross BloodDonation Centre (Bern, Switzerland). PBMCs were obtained by
Pancoll density centrifugation and monocytes were isolated by Monocyte Isolation Kit II (Mil-
tenyi Biotex GmbH). MDMs were generated by culturing in RPMI 1640 medium (Invitrogen)
supplemented with 10% FCS, 1% L-glutamine (2 mM, Invitrogen), 1% penicillin/streptomycin
(100 U/ml, Invitrogen), 10 ng/mlM-CSF (R&D Systems) for 8 days at 37°C/5%CO2. Where
indicated, macrophages were incubated with LPS (100 ng/ml) and IFN-γ (20 ng/ml) for 24h to
induceM1 or incubated with IL-4 (20 ng/ml) for 24h to induce differentiation into M2 [25].
Human Epithelial Cell Line
Differentiated SV-40 transformed human bronchial epithelial cell line (16HBE14o- cells) was
maintained in MEM 1X, with Earle’s Salts, without L-Glutamine (Gibco BRL Life Technologies
Invitrogen AG, Basel, Switzerland) supplemented with 1% glutamine/penicillin/streptomycin
(Gibco BRL) and 10% FCS (Gibco BRL). About 5x106 cells were seeded in collagen coated
(Pure Col, Purified Bovine Collagen Solution, Advanced Biomatrix, 1:50) T75 flasks (Falcon,
US) for further cell culture at 37°C/5%CO2.
Primary Human Nasal Epithelial Cells
Ten healthy adult volunteers were recruited for a brushing of the inferior surface of the middle
turbinate of both nostrils in order to obtain airway epithelial cells. This was performed by
using a cytological brush (Dent-O-Care, No 720, London, UK) [26]. The study protocol was
approved by the Ethics Committee of the Canton of Bern, Switzerland (KEK 77/09). Informed
written consent was obtained from all study participants. Cells were grown in Bronchial Epi-
thelial Basal Medium (BEBM, Lonza, Switzerland) supplemented with Single Quots (SQ,
Lonza, Switzerland) and seeded in uncoated T25 flasks (Falcon). When reaching 80–100%
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confluency cells were detached with trypsin (Gibco BRL) and 105 cells were seeded per
uncoated insert (0.4 μm pore size, sealed PET capillary pore membrane, 12 well plate; Greiner
Bio-One, Germany).
Air-Liquid Interface (ALI) Cultures
Primary human nasal epithelial cells grown on inserts (as described above) were differentiated
in Maintenance medium (PneumaCult-ALI supplemented with 6 μl Maintenance, 3 μl Hydro-
cortison, 1.2 μl Heparin (Stemcell), 0.9 μl Primorcin (InvivoGen, US)) given to the lower cham-
ber, while the apical side of the epithelial cells remained facing air. Cells were cultured for 8
weeks for full differentiation.
Human Epithelial Progenitor Cells (EpCAM+) and Pericytes (EpCAM-)
To prospectively isolate lung pericytes and epithelial cells, we used lung specimens obtained
from patients following surgical resection for early stage lung cancer. All patients gave
informedwritten consent for usage of surgical material for research purposes, which was
approved by Ethics Commission of the Canton of Bern, CH (KEK-BE:042/2015). Preparation
of lung tissue and cell sorting was performed as previously describedwith modifications [27].
Briefly, normal appearing lung tissue was resected from the tumor foci at a distance> 5 cm
and digested using a solution of collagenase I and II (Worthington Biochemical Company).
Digestion of lung tissue was halted following the addition of 10% FBS (Invitrogen). Single cells
were stained with a panel of fluorescently conjugated human monoclonal antibodies directed
at the following epitopes (all eBioscience): CD45-PB, CD14-PB, CD31-PB, CD235a-PB,
CD73-APC and CD90-FITC, EpCAM-PE-Cy7. To exclude dead cells, 7-AAD (eBioscience)
was added prior to sorting. Proper placement of gates was determined using fluorescence
minus one strategy [28,29]. Cells were sorted using a BD FACS Aria III (BD Biosciences,
Franklin Lakes, NJ, USA). A fraction of mesenchymal cells simultaneously expressing CD73
and CD90, while lacking the epithelial cell adhesion marker EpCAM and the lineage markers
CD45, CD14, CD31 and CD235a were directly cultured in a 6-well tissue culture plate pre-
coated with 0.1% gelatin in alpha-MEM (Sigma) supplemented with 1% FBS (Gibco), 20 ng/
mL of recombinant human FGF2 (Gibco), 25 ng/mL of recombinant human EGF (Gibco), 1.25
mg of human Insulin (Sigma), 1% pen-strep (Sigma). An epithelial fraction simultaneously
expressing EpCAM and CD73 while lacking CD90 and lineage markers were cultured in 6 well
plates precoated with a solution of human collagen I (Sigma) and human collagen IV (Sigma)
and grown in CNT-PA plus (CELLNTEC, Bern, CH). Cells were grown at 37°C, 5% CO2 and
low O2 (3%) until reaching confluence and expanded in their respectivemedia.
Triple Co-Culture
The triple co-cultures were prepared as previously described [30,31]. The 16HBE14o- cell line
(initial number of 0.5 x 106 cells) was grown on cell culture inserts (3.0 μm pore size, sealed
PET capillary pore membrane, 12 well plate; Greiner Bio-One, Germany) that were previously
coated with collagen (Advanced Biomatrix). After three days expansion time, the confluent
monolayer of 16HBE cells was supplemented with differentiatedMDMs and MDDCs as fol-
lows: MDDCswere harvested, washed, centrifuged and resuspended in MEMmedium and
2.5x105 cells in 75 μl mediumwere added to the basal side of the inserts placed upside down on
a petri dish. The petri dish with the inserts was covered and placed in the incubator for 1.5h–
2h. MDMs were harvested by washing with PBS followed by addition of 380 μl Accutase
(Gibco BRL). Plates were placed in the incubator for 5–10 min. Cells were then detached with
cell scrapers (Semadeni, Ostermundigen, Switzerland). The activity of Accutase was stopped by
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addingMEM. A volume of 500 μl containing 1.9x105 cells was added on the apical side of the
epithelial monolayer on the insert, forming the upper chamber. After 2h, 750 μl of MEM
mediumwas added to the lower chamber.
Uptake of Virosomes and Liposomes
To study uptake of virosomes and liposomes, cells of interest were cultured for 18h at 37°C in
presence of virosomes, liposomes or controls. One ml of suspended cells was incubated for 18h
with virosomes (5 μg HA), liposomes, or control (PBS) in the same dilution as virosomes.
Uptake was determined by measuring Atto647 signal by flow cytometry (LSRII, BD Biosci-
ences, Franklin Lakes, NJ, USA). Data was analyzed using FlowJoX (TreeStar, Ashland, OR,
USA) software.
Phenotyping of Cells
MDDC and MDM phenotype was determined by flow cytometry after treatment with viro-
somes, liposomes or appropriate controls for 18h. One ml of cell suspension was incubated
with virosomes (5 μg HA), liposomes in the same dilution, or the following controls: medium
only, PBS in the same dilution as virosomes, LPS (100 ng; Sigma) or inactivated influenza
virus A/Brisbane (5 μg HA). 16HBE cells were collected by trypsinisation (Gibco BRL),
MDMs and triple co-cultures were resuspended by Accutase digestion (Gibco BRL) and by
cell scraping. Cells were treated with FcR block on ice followed by viability staining with
Fixable Viability Dye eFluor506 (eBioscience,Vienna, Austria) for 30 min on ice. As positive
controls, cells heated at 65°C for 15 min or frozen at -80°C for 30 min were used. Unless
indicated otherwise, antibodies were purchased from eBioscience and utilised with
appropriate isotype controls. For MDMs: CD14-Alexa Fluor 700, CD68-PE-eFluor610,
CD163-PerCPeFluor710, CD40-APC-Cy7 (Biolegend, London, UK), HLA-DR-Brilliant Violet
785 (BioLegend),CD86-Brilliant Violet 605 (BioLegend),CD80-Brilliant Violet 421 (BioLegend,
CD206-PE-Cy7, CD36-APC-Cy7 (BioLegend). For MDDCs: CD11c-Pe-Cy7, CD1c-Alexa Fluor
700 (BioLegend),CD83-PE-Cy7 (BioLegend), PD-L1-eFluor450, PD-L2-PerCP-eFluor710 and
CCR7-APC-eFluor780. For epithelial cells and triple co-cultures additionally:CD209-PE-Cy7
(DC-Sign),CD86-PE and CD326-Brilliant Violet 650 (EpCAM; BioLegend). Flow cytometrywas
performedby using flow cytometry SORP LSR II (BD Biosciences).
Intracellular Cytokine Staining
Cells were treated with 20 μg/ml Brefeldin A (eBioscience) to stop protein transport. Subse-
quently, cells were stained for surface markers as mentioned above. Cells were fixed in 1% for-
malin solution followed by intracellular staining with the following anti-cytokine antibodies
with appropriate isotype controls diluted in permeabilization buffer (PBS + 0.1% saponin
+ 10% FCS): IL-10-Alexa Fluor 488, IL-12-PE (all eBioscience).
Cytokine Detection
Medium of the upper chamber of the triple co-cultures and supernatant of 16HBEmono-cul-
tures were collected and production of IL-8, IL-1β and TNF-α was analysed by employing
ELISA Kits from R&D Systems (Minneapolis, US) according to the manufacturer’s specifica-
tions. Optical density was measured with a microplate reader (Tecan reader) at a wavelength of
450nm.
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Laser Scanning Microscopy
Particle uptake was confirmed using laser scanningmicroscopy (LSM) to detect Atto647 emis-
sion in cells. PHNECs were fixed in 70% ethanol and permeabilizedwith 0.2% Triton X-100
(Sigma-Aldrich). Cells were stained with primary antibodiesmouse anti-β-tubulin (1:100; Life
Technologies), rabbit anti-occludin (1:50; Molecular Probes) or rabbit anti-mucin (1:50; Santa
Cruz Biotechnology) overnight at 4°C. The following secondary antibodies were used for 1h at
room temperature: goat anti-mouse Alexa488 (1:200; Molecular Probes), goat anti-rabbit
Alexa546 (1:200; Life Technologies) and phalloidin Atto390 (1:25; ATTO-TEC). Cells were
washed and embedded in Aquatex mounting medium (Merck KGaA, Darmstadt, Germany).
Optical sections were taken with a Zeiss LSM 710 (Carl Zeiss AG, Feldbach, Switzerland) with
a 40x oil objective (Plan-Apochromat 40x/1.40 Oil) and a digital zoom of 1.4x. Image process-
ing was performed using Imaris (Bitplane AG, Zurich, Switzerland) software.
Statistics
Statistical analyses were conducted using R version 3.2.1 [32]. All graphical representations
were prepared using the R package ggplot2 [33]. Differences in measured frequency and mean
fluorescence intensity (MFI; median) between groups were tested using an ANOVA. Main
effects of treatment (consisting of virosomes, liposome and control where appropriate) and cul-
ture type (consisting of mono- or co-culture) were included in the model. Tukey’s honest sig-
nificant difference (HSD) post hoc test was used to investigate individual paired comparisons.
Where shown to be significant, the effect of Atto647 was included as a covariate. Appropriate-
ness of ANOVA models was verified by analysing the residuals. Experiments are all biological
repetitions stated in each figure legend.
Results
Virosome and Liposome Characterization
Influenza virosomes and liposomes were extensively characterized for particle size, homogene-
ity, as well as HA content and endotoxin contamination. Particle size was measured by DLS
and NTA that routinely provided a hydrodynamic diameter (particle diameter plus water
shell) of 90–96 nm, and particle sizes of 84–86 nm for all nanocarrier formulations respectively
(Table 1). Nanoparticle quality was consistently uniform and reproducible throughout all
Table 1. Characterization of virosomes and liposomes.
Samples DLS1 NTA2
Size ± SD (nm)3 PDI4 Size ± SD (nm)5
Virosome 95.0 ± 0.6 0.03 85.3 ± 0.8
Virosome-Atto647 95.6 ± 0.7 0.04 84.9 ± 0.5
Liposome 90.0 ± 1.7 0.02 85.5 ± 0.8
Liposome-Atto647 90.8 ± 2.5 0.03 84.0 ± 0.4
Influenza virosomes and liposomes with or without conjugated fluorochrome Atto647 were analyzed for
particle size by DLS and NTA. One representative measurement from two independent formulations of
virosomes and liposomes is shown.
1 Dynamic light scattering
2 Nanoparticle tracking analysis
3 Hydrodynamic diameter
4 Poly Dispersity Index
5 Modal particle size.
doi:10.1371/journal.pone.0163539.t001
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experiments performed. Protein concentration of HA was determined by performing
SDS-PAGE, Spotblot and Western Blot (data not shown). The HA concentration was consis-
tently around 50 μg/ml (data not shown). In exposure experiments influenza virosomes were
further employed at a concentration of 5 μg/ml HA, whereas liposomes and PBS were utilized
at the same dilution factor. Routine endotoxin measurements of virosomes and liposomes by
LAL test yielded consistent results below the threshold of 10.0 EU/ml in the concentrated for-
mulations (data not shown).
Treatment with Virosomes or Liposomes Does Not Induce Cell Death
Potential cytotoxic effectswere determined prior to analysis of particle uptake and phenotype
change. Cells were incubated with virosomes, liposomes or appropriate controls. Cells kept for 15
min at 65°C or stored at -80°C for 30 min served as positive controls and showed a high cell
death rate (data not shown). Less than 10% of dead cells were detected in all cell types after expo-
sure to particles compared to PBS treated cells in culture (S1 Fig). The evaluated concentration of
virosomes was 5 μg/mlHA, and this was therefore chosen as an optimal concentration for all
subsequent experiments. Dead cells were always excluded for further flow cytometry analyses.
Uptake Efficiency Differs between Virosomes and Liposomes
In order to investigate whether virosomes and liposomes are taken up by different cells of the
respiratory tract and to compare their dynamics in mono- and triple co-culture, cells were
incubated with virosomes, liposomes or a PBS control. For triple cell co-cultures gating was
performed for size, single cells, live cells and split into EpCAM+ cells for 16HBE and EpCAM-
cells. EpCAM- cells were further divided into DC-Sign+ (for MDDCs) and DC-Sign- (for
MDMs; S2A Fig). Mono-cultures were gated for single, live cells followed by EpCAM+ cells for
epithelial cells, CD1c+ and CD11c+ double positive cells for MDDCs (S2B Fig) and CD14+ and
CD68+ double positive cells for MDMs (S2C Fig).
In MDDCs uptake of both nanocarrier types was observedwith significantlymore cells cap-
turing virosomes than liposomes in both mono- and co-culture (p<0.001; Fig 1A). Interest-
ingly, liposomes were taken up by less MDDCs in co-culture compared to mono-culture
(p<0.001; Fig 1A). Furthermore, in MDDCsmore virosomes than liposomes were taken up
per cell in mono-culture as measured by MFI (p<0.001; Fig 1B), whereas significantly less viro-
somes were taken up per cell in co-culture compared to mono-culture (p = 0.002; Fig 1B).
In co-culture,MDMs showed higher uptake frequency for virosomes than liposomes
(p<0.001; Fig 1A). Similar to MDDCs,MDMs in mono-cultures took up significantlymore
liposomes than in co-cultures (p<0.001; Fig 1A). The amount of particles taken up per cell was
similar in mono- and co-culture.
Significantly more 16HBE cells in both mono- and co-culture captured virosomes than lipo-
somes (p<0.001; Fig 1A). Compared to virosome uptake in 16HBE mono-cultures, 16HBE co-
cultures showed reduced virosome uptake (p = 0.023; Fig 1A). Regarding particle uptake per
cell in 16HBE mono-cultures, a higherMFI was detected for virosomes than liposomes
(p<0.01; Fig 1B). Virosome uptake in frequency (p<0.05) and MFI (p<0.01) was higher in
16HBEmono-culture than in PHNECmono-culture (Fig 1).
Human epithelial progenitor cells (EpCAM+) internalizedmore virosomes than liposomes
according to MFI (Fig 1B). Both virosomes and liposomes were taken up by EpCAM+ cells
with a much higher efficacy than by 16HBE or PHNECs (p<0.001; Fig 1). Matched EpCAM-
cells took up both virosomes and liposomes successfully (S3 Fig).
Particle uptake in PHNEC was confirmed by LSM. Cells were stained for β-Tubulin (cilia),
phalloidin (actin cytoskeleton) and either occludin (tight junctions; Fig 2) or MUC5AC
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(mucin; Fig 3). Virosomes and liposomes were taken up and localised both intracellularly and
apically between cilia.
Characterization of Phenotype and Cytokine Profile after Virosome and
Liposome Treatment in Mono- and Co-Cultures
We next investigated whether treatment virosomes or liposomes induceMDMs, MDDCs and
16HBE phenotype changes or activation by expression of co-stimulatory surfacemolecules in
both mono- and co-cultures.
16HBE cells were analysed by flow cytometry for surface expression of HLA-DR, CD40,
CD80 and CD86, but no significant changes were detected (S4 Fig).
For MDDCs we analyzed the phenotypic and co-stimulatorymarkers HLA-DR, CD40,
CD80, CD86, CD83, PD-L1, PD-L2, CCR7 and intracellular cytokines IL-10 and IL-12 with
respect to their relevant isotype controls. The marker CD86 showed significant upregulation
after treatment with virosomes in mono-culture compared to PBS (p<0.01) and in co-culture
after PBS (p<0.001) or liposome (p = 0.05) treatment compared to mono-culture (Fig 4). The
other markers showed no phenotype change in mono-culture (S5 Fig). To confirm that
MDDCs were able to undergo activation, positive controls (LPS, inactivated influenza virus)
were employed that showed high expression of surfacemarkers in MDDCs (S7 Fig).
MDMs were analysed for HLA-DR, CD40, CD80, CD86, CD163, IL-10 and IL-12. The
main effect observedwas higher CD86 expression per cell in co-culture compared to mono-
Fig 1. Uptake of virosomes or liposomes in mono- (MO) or co-culture (CO). MDDCs (DCs), MDMs (macrophages), 16HBE, PHNEC and human
epithelial progenitor cells (EpCAM+) were incubated with either virosomes (VIRO), liposomes (LIPO) or control (PBS) for 18h at 37˚C. Uptake of virosomes
and liposomes was determined by measuring Atto647 signal by flow cytometry. Frequency (A) and MFI (B) are shown relative to PBS. Data represents at
least four independent experiments. Statistical significance was determined by ANOVA followed by Tukey’s HSD post hoc test to investigate individual
paired comparisons. *p<0.05; **p<0.01; ***p<0.001.
doi:10.1371/journal.pone.0163539.g001
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culture (p<0.01; Fig 5B), whereas no significant differences were detected for the other markers
(Fig 5 and S6 Fig). To confirm that MDMs were able to undergo activation, positive controls
Fig 2. Exposure of virosomes or liposomes to PHNEC ALI culture. Uptake of liposomes (A) or virosomes (B) following
treatment in PHNEC ALI culture was analyzed by LSM. Micrograph was obtained from three-dimensional stacks of
consecutive optical sections and analyzed with Imaris software. Green: cilia (β-Tubulin), red: liposomes/virosomes, blue:
actin cytoskeleton, white/yellow: tight junctions (occludin). (1) xy-projections (top panel) and xz-projections (lower panel)
(2, 3) 3D reconstruction of cilia, virosomes and tight junctions, view from top (2) and view from the side (3). One
representative experiment from three independent experiments is shown.
doi:10.1371/journal.pone.0163539.g002
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for MDMs (LPS, inactivated influenza virus) were employed that showed high expression of
surfacemarkers (S8 Fig).
Minimal changes in the cytokine profile were observed in 16HBEmono- and co-cultures after
treatment with virosomes or liposomes.Although an increase in IL-8 secretionwas observed in co-
cultures after treatment with virosomes (p = 0.034), the effectwas also observedwith PBS (p = 0.011)
and thereforemight not be related to nanocarriers.No significant changes were measured for IL-1β
(Fig 6), and levels of TNF-αwere below detection limit in all conditions (data not shown).
Taken together, we observedminimal differences between virosome- and liposome-induced
phenotypic and co-stimulatorymarker expression in different cell types, either in mono- or co-
culture. MDDCs overall underwentmoderate activation compared to MDMs and 16HBE cells.
Uptake of Virosomes and Liposomes in M1 and M2 Differentiated
Macrophages
Following polarization into M1 and M2macrophages we analyzed uptake in these cells for
both liposomes and virosomes. There was no significant difference in frequency of virosome or
Fig 3. Mucus staining of PHNEC ALI following virosome or liposome exposure. The effect of liposomes (A) or virosomes (B)
exposure was analyzed by LSM. Micrographs were obtained from three-dimensional stacks of consecutive optical sections and
analyzed with Imaris software. Green: cilia (β-Tubulin), red: liposomes/virosomes, blue: actin cytoskeleton, yellow: mucin. xy-
projections (top panel) and xz-projections (lower panel) (1) merged image (2) cilia and liposomes/virosomes (3) mucin and
liposomes/virosomes. One representative experiment from three independent experiments is shown.
doi:10.1371/journal.pone.0163539.g003
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liposome uptake (Fig 7A), but the inMFI was significantly higher for virosomes than liposomes
in M2 macrophages (p<0.001; Fig 7B) and significantlymore virosomes were taken up by M2
than by M1 cells (p<0.001; Fig 7B). In summary, M2 differentiatedmacrophages took up more
of both bio-mimetic nanocarriers than M1 differentiatedmacrophages. Also, M2 differentiated
macrophages took up significantlymore virosomes than liposomes.
Phenotype of M1 and M2 Differentiated Macrophages after Treatment
with Virosomes and Liposomes
MDMs differentiated into M1 and M2 were further analysed for phenotype changes after addi-
tion of virosomes or liposomes to detect whether exposure to these nanocarriers is affecting
phenotype and function of macrophages that have undergone polarization. In vitro differentia-
tion resulted in macrophage populations with a M1 (HLA-DR, CD80, CD86) and M2 pheno-
type (CD36, CD163, CD206). Following treatment of virosomes and liposomes, the surface
phenotypes of bothM1 and M2 macrophages remained unchanged (Fig 8). Overall, there was
no phenotype change upon virosome or liposome treatment.
Discussion
In recent years, influenza virosomes have successfully been developed for influenza and hepati-
tis A vaccines and as carrier systems for heterologous antigens for malaria, HIV or other patho-
gens [18]. In addition to their carrier function, virosomes possess an intrinsic immune-
potentiating effect due to their surface structure consisting of incorporated influenza envelope
proteins [18]. To date there is lack of knowledge on the interaction of nanocarriers like viro-
somes with immune cells of the respiratory tract that may provide a potential target for thera-
peutic immune-modulation through pulmonary administration [1]. Airway epithelial cells,
alveolar macrophages and pulmonaryDCs are the key players involved in maintaining barrier
functions and inducing innate and adaptive immune responses. To study the interaction of
nanoparticles with such cells through a more realistic approach, a human triple co-culture
model with a bronchial epithelial cell line and primaryMDDCs and MDMs was established
and compared to respectivemono-cultures [30,31,34].
Our in vitro triple co-culturemodel aims to reproduce the in vivo situation in humans with
macrophages on the luminal side of the epithelium [35,36] and immature DCs within the lam-
ina propria [37]. Such a model is of particular interest to investigate the ability of virosomes
and liposomes to traverse the epithelial airway barrier in the respiratory tract, in which inhal-
able nanocarrier-based vaccines may interact with APCs such as DCs in the airway mucosa
and affect downstream immune responses [38,39]. Intranasal sprays for virosome-based clini-
cal vaccine candidates already exist [18,40] and could possibly be employed as a basis for novel
therapeutic strategies with inhalable immune-modulators to treat allergic asthma.
ThoughMDDCs in our in vitro model are localized underneath the insert membrane and
are therefore not directly exposed to particles upon treatment, we detected efficient and rapid
uptake, especially of virosomes. It has been shown that large particles are taken up by DCs situ-
ated underneath the epithelium without affecting the epithelial cell layer integrity [41]. Several
explanations are provided for this phenomenon: DCsmay extend cytoplasmic processes or
Fig 4. Expression of surface markers in MDDCs upon uptake of virosomes or liposomes. Cells in mono- (MO) or co-culture (CO)
were incubated for 18h with either virosomes (VIRO), liposomes (LIPO) or controls (PBS, as shown). Expression of surface molecule
markers HLA-DR, CD40, CD80, and CD86 were measured by flow cytometry. Figures show the receptor expression in frequency (A)
and MFI (B) of six independent experiments. Statistical significance was determined by ANOVA followed by Tukey’s HSD post hoc test
to investigate individual paired comparisons. *p<0.05; **p<0.01; ***p<0.001.
doi:10.1371/journal.pone.0163539.g004
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dendrites through epithelial tight junctions [42,43], or DCsmigrate as a whole through the epi-
thelium to capture antigen [44,45]. A study performed in a similar triple co-culturemodel
showed that MDDCs extended long processes through the pores of the inserts to spread out
directly underneath the epithelium or between epithelial cells to the apical side to capture 1 μm
polystyrene particles, someMDDCs were found to have completely translocated to the apical
side [2]. We assume similar cell-cell interactions in our co-cultures following exposure to viro-
somes or liposomes. It is of interest to mention that 16HBE cells generate a higher transepithe-
lial electrical resistance (TEER) than the more commonly used alveolar A549 cells [14], a
finding that has also been demonstrated for monolayers [46]. However, this high TEER of
16HBE does not affect particle uptake in underlying cells as we could clearly demonstrate
uptake by MDDCs. Our triple co-culturemodel using the bronchial epithelial cell line 16HBE
more closely resembles the airway than the alveolar cell line A549.
The uptake of virosomes by MDDCs is an essential result provided herein, since DCs have
the ability to prime naïve T-lymphocytes [5] and regulate subsequent differentiation into effec-
tor T cells in order to modulate specific downstream immune responses [1]. Knowing that
nanocarriers are able to pass the epithelial membrane and actually reach the underlying DCs is
not only promising for potential therapeutic immune-modulatory strategies targeting the lung,
but also for vaccination approaches to generate immunity, e.g. for respiratory syncytial virus
(RSV), influenza or tuberculosis.However, optimal human in vitro conditions would include
primary epithelial cells instead of a cell line. To investigate possible differences between epithe-
lial cells of primary versus cell line origin, we analysed virosome and liposome uptake in paral-
lel in both mono-cultures. Fully differentiated PHNECs were used as a surrogate cell type for
bronchial epithelial cells in large airways, as it has been recently shown that readily accessible
Fig 5. Expression of surface markers in MDMs upon uptake of virosomes or liposomes. Cells in mono- (MO) or co-culture (CO)
were incubated for 18h with either virosomes (VIRO), liposomes (LIPO) or controls (PBS, as shown). Expression of surface molecule
markers HLA-DR, CD40, CD80, CD86 and CD163 were measured by flow cytometry. Figures show the receptor expression in frequency
(A) and MFI (B) of six independent experiments. Statistical significance was determined by ANOVA followed by Tukey’s HSD post hoc
test to investigate individual paired comparisons. *p<0.05; **p<0.01; ***p<0.001.
doi:10.1371/journal.pone.0163539.g005
Fig 6. IL-1β and IL-8 secretion in 16HBE cells. Cells in mono- (MO) or co-culture (CO) were incubated for 18h with
either liposomes (LIPO), virosomes (VIRO) or controls (PBS, as shown). Supernatants were collected to perform IL-1β
and IL-8 ELISA. Data represents six independent experiments. Statistical significance was determined by ANOVA
followed by Tukey’s HSD post hoc test to investigate individual paired comparisons. *p<0.05.
doi:10.1371/journal.pone.0163539.g006
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Fig 7. Uptake of virosomes or liposomes by M1 and M2 differentiated macrophages in mono-cultures. Cells in mono-
cultures were differentiated for 24h into M1 and M2 type macrophages before being incubated for 18h with either virosomes
(VIRO), liposomes (LIPO) or controls (PBS). Uptake of virosomes and liposomes was determined by measuring Atto647
signal by flow cytometry. Frequency (A) and MFI (B) are shown relative to PBS. Data represents six independent experiments.
Statistical significance was determined by ANOVA followed by Tukey’s HSD post hoc test to investigate individual paired
comparisons. *p<0.05; **p<0.01; ***p<0.001.
doi:10.1371/journal.pone.0163539.g007
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nasal epithelial cells are comparable to bronchial epithelial cells that require more invasive
sampling techniques such as bronchoscopic bronchial brushings [47]. Despite the fact that
PHNECs secretedmore mucus than the epithelial cell line 16HBE, virosome uptake was still
efficient and occurred at higher frequencies than for liposomes. Nevertheless, LSM analyses
showed remaining particles in cilia and mucus on the apical side of PHNECs, explaining the
lower uptake in PHNECs in comparison to 16HBE. Technically it was not possible to integrate
PHNECs in the co-culturemodel, since primary cultures are not able to completely differenti-
ate when grown on membranes with 3–4 μM pore-size which are required in order to provide
unimpeded interactions between cells grown on either side of the membrane [48]. EpCAM+
cells are primary epithelial progenitor cells located in small airways [49] and were employed as
a comparison to PHNECs that are also primary cells, but originate from larger airways and
16HBE, representing a cell line. With EpCAM+ epithelial progenitor cells we showed that both
virosomes and liposomes were taken up in higher quantity per cell than by 16HBE or PHNECs.
EpCAM- cells, representing pericytes [27], took up significantly less virosomes compared to
their EpCAM+ counterparts. Indeed, it was shown earlier in vivo that influenza virus is able to
infect EpCAM+ epithelial progenitor cells in the lung of mice [50]. These findings highlight
that pulmonary epithelial cells, as potential targets for novel therapeutic approaches employing
virosomes or liposomes, display strikingly different uptake characteristics. Despite the above
limitations, the established co-culturemodel still represents an appropriate and feasible model
of the human respiratory tract airway barrier to test novel bio-mimetic nanocarrier compounds
that are being developed for pulmonary administration and modulation of mucosal immune
responses in the lung [30].
Overall, there was more uptake of virosomes and liposomes in APCs compared to epithelial
cells, consistent with other studies employing a triple co-culturemodel exposed to other parti-
cles [31], despite AECs being known to be a main target for respiratory viruses such as influ-
enza virus, rhinoviruses (RH) [51], and RSV [52]. APCs may display higher uptake than
epithelial cells for various reasons: One important difference is their phagocytic activity and as
macrophages are twice as phagocytic as immature DCs, they take up even more nanoparticles
than MDDCs or epithelial cells [53].
The virosomal bilayer contains viral envelope proteins such as hemagglutinin and neur-
aminidase that both bind to sialic acid residues and trigger highly efficient receptor-mediated
uptake. Liposomes, on the contrary, lack such viral proteins and thus are taken up mostly by
macropinocytosis or endocytosis [54]. In co-cultures the uptake of liposomes and virosomes
was generally decreased compared to mono-cultures. Previous studies showed inhibitory
effects of alveolar macrophages on DCmaturation both in vivo and in vitro [9,55]. Inhibition
of DCsmay partly be due to release of NO by macrophages and epithelial cells, which caused
abrogated expression of MHC Class II [9]. However, in our model we observed a tendency of
increasedHLA-DR expression on MDDCs in co-culture compared to MDDCs in mono-cul-
ture. Significantly decreased particle uptake in co-cultures compared to monocultures as
observed in MDDCs and epithelial cells may be due to the location of MDDCs underneath the
epithelial barrier, impairing direct uptake of virosomes or liposomes administered to the upper
chamber. In contrast, epithelial cells with macrophages located at their apical side may take up
less particles due to clearance by the macrophages. We recently reported that polystyrene
Fig 8. Expression of surface markers in M1 and M2 differentiated MDMs upon uptake of virosomes or liposomes in mono-culture. Cells in
mono-culture were differentiated for 24h into M1 or M2 macrophages before being incubated for 18h with either virosomes (VIRO), liposomes (LIPO)
or controls (PBS). Expression of surface molecule markers HLA-DR, CD80, CD86, CD36, CD163 and CD206 were measured by flow cytometry.
Figures show the receptor expression in frequency (A) and MFI (B) of six independent experiments. Statistical significance was determined by
ANOVA followed by Tukey’s HSD post hoc test to investigate individual paired comparisons. *p<0.05; **p<0.01; ***p<0.001.
doi:10.1371/journal.pone.0163539.g008
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nanoparticles of different sizes administered intra-nasally in mice were mainly taken up by
alveolar macrophages, as compared to DCs located in the epithelium of the airways and the
alveoli, underlining the appropriateness of the present in vitro triple co-culture as a model sys-
tem for the pulmonary epithelial barrier. In addition to HLA-DR, CD86 was increased in
MDDCs following treatment with virosomes and liposomes, compared to PBS control, suggest-
ing a moderate degree of DC activation. In contrast, MDMs treated with virosomes or lipo-
somes showed no significant difference in phenotypic markers compared to PBS control.
Though there was a tendency for upregulation of markers like CD40 in co-cultures compared
to mono-cultures, this change did not reach statistical significance.Macrophage polarization
associated with different respiratory disorders like asthma has received increased attention in
recent years, reflecting the importance and plasticity of this population in health and disease
[56–58]. We tested whether treatment with virosomes or liposomes would induce phenotype
changes of macrophages that have undergone polarization. Polarization was monitored
through the expression of markers HLA-DR, CD80 and CD86 for M1 and CD36, CD163 and
CD206 for M2 [59]. Following treatment for 18h with virosomes or liposomes, we failed to
detect any significant phenotypic changes in either macrophages population. It has previously
been reported that an increasedM2 differentiation occurs in allergic asthma due to a skewed
Th2 immune response [57,60,61]. M1 macrophages on the other hand were associated with
less severe asthma and an increase in Th1 and Th17 cells [62,63]. Therefore, it may be advanta-
geous to shift the macrophage phenotype in asthmatic patients from a M2 type to a M1 type. It
has been shown in vitro that differentiatedmacrophages can be switched back to M0 state by
using specificmedia [64], an approach that may be of interest in vivo, too. Other studies sug-
gest to treat macrophages with PGE2 to inhibit M2 macrophage development [56], a molecule
that may be administered with virosomes and liposomes as carriers. Specifically, targetingM2
cells to transdifferentiate into a M1 phenotype may help reprogram a skewed immune balance
in the lung by generating Th1-like immune response. Due to the fact that in our experiments
M2 macrophages showed increased uptake of virosomes compared to M1, these nanoparticles
show potential to be used as a carrier for molecules such as PGE2 to switch polarization of M2
macrophages. In addition to our findings, it has been shown earlier that M2 cells show higher
phagocytic activity for pathogens than M1 cells [65]. The underlyingmechanismmight be due
to high CD206 expression, a macrophage mannose receptor important for phagocytosis [66].
For this reasonM2macrophages would not need to be specifically targeted as their CD206
may be involved in internalization of different particle types.
In our co-culture experiments a moderate increase of HLA-DR and CD86 expression
occurred after treatment with both virosomes and liposomes, as well as with PBS, when com-
pared to mono-cultures. A possible explanation may be the interplay of the different cell types
via cell-cell contact or the release of cytokines facilitating activation in the co-culturemodel
compared to mono-cultures. As an example, secretion of cytokines like thymic stromal lym-
phopoietin (TSLP) by epithelial cells may play an important role [15]. As reviewed in Ziegler
et al, TSLP can induce several phenotype changes on human DCs, including upregulation of
MHC class II, CD40 and CD86 [16]. Furthermore, epithelial cells are able to secrete other fac-
tors that regulate DC function such as GM-CSF, IL-25, IL-33 and IL-4. In order to determine
pro-inflammatory cytokine profiles, we measured IL-8 and IL-1β in supernatants from 16HBE
monocultures and in the lower compartment of triple co-cultures. IL-8 is known to be secreted
by epithelial cells as well as by macrophages [67] and was shown to be significantly increased
in triple co-cultures compared to 16HBE mono-cultures. A similar observationwas also appli-
cable to IL-1β, which is mainly secreted by macrophages and DCs [67], both present in the tri-
ple co-culture.Müller et al [68] studied oxidative stress and inflammation response after
nanoparticle exposure in a triple co-culturemodel [24] and based on their findings it is likely
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that the synergistic interaction of the three cell types modulate the release of cytokines and che-
mokines.We suggest that such a similar effect partly explains the observed increase in secretion
of pro-inflammatory cytokines and upregulation of activation markers in the triple co-culture
compared to mono-cultures.
In conclusion, our data underlines that the triple co-culturemodel provides an appropriate
experimental system that realistically simulates the complexity of the airway barrier, enabling to
investigate how particle-cell interactions and the interplay betweendifferent cell types affects
responses to novel treatments developed for the pulmonary administration. To improve the cur-
rent model, particles could be applied by means of a microsprayer or air-liquid interface cell expo-
sure system [69]. Such an experimental setup would enable the screening of various types of
derivatized virosomes and other nanoparticles for their ability to modulate immune responses in
the respiratory tract, e.g. re-programming Th2-biased immune response in allergic asthma [70].
Cell-cell interactions in co-cultures affected particle uptake and release of pro-inflammatory cyto-
kines partly reflecting the complex in vivo setting. The data demonstrated that in vitro key APCs
avidly take up virosomes, yet without inducing strong activation, as measured by phenotype
change or cytokine release in treated cells. This salient finding underlines the potential of such
bio-mimetic particles to target immune cells in the respiratory tract, but without inducing exces-
sive inflammatory responses that may jeopardise gaseous exchange and lung function. This char-
acteristicmakes virosomes attractive bio-mimetic nanocarriers for pulmonary antigen delivery for
novel immune-modulatory strategies in the respiratory tract in disorders such as allergic asthma.
Supporting Information
S1 Fig. Cell viability after administration of nanoparticles.After incubating cells with influ-
enza virosomes (VIRO, with (4) and without () Atto647), liposomes (LIPO, with (4) and
without () Atto647) or control (PBS) for 18h, viability was tested employing a fluorescence
viability dye and measuring its signal with flow cytometry. Data represents at least six indepen-
dent experiments relative to PBS. Statistical significancewas determined by ANOVA followed
by Tukey’s HSD post hoc test to investigate individual paired comparisons.
(EPS)
S2 Fig. FACS gating strategies.Cells of interest were gated according to forward and sideward
scatter (FSC/SSC). Doublets were excluded by gating for single cells (FCS-W/FCS-H).Viability
was determined by using two positive controls (65°C for 15 min and -80°C for 30 min). (A)
FACS gating for triple co-culture and 16HBE cells. EpCAM+ cells are 16HBE cells, EpCAM-
cells are further divided into DC-Sign+ (DCs) and DC-Sign- (macrophages) (B)Double posi-
tive CD1c+ and CD11c+ MDDCswere gated according to relevant FMO (fluorescenceminus
one). Phenotypic and co-stimulatorymarkers were analyzed according to their relevant isotype
controls. (C)Double positive CD14+ and CD68+ MDMs were gated according to relevant
FMO. Phenotypic and co-stimulatorymarkers were analyzed according to their relevant iso-
type controls.
(EPS)
S3 Fig. Uptake of nanoparticles in EpCAM- mono-culture.Cells were incubated with either
virosomes (VIRO), liposomes (LIPO) or control (PBS) for 18h at 37°C. Uptake of virosomes
and liposomes was determined by measuring Atto647 signal by flow cytometry. Frequency and
MFI are shown relative to PBS. Data represents four independent experiments. Statistical sig-
nificance was determined by ANOVA followed by Tukey’s HSD post hoc test to investigate
individual paired comparisons.
(EPS)
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S4 Fig. Expression of surfacemarkers in 16HBE cells upon uptake of nanoparticles.Cells in
mono- (MO) or co-culture (CO) were incubated for 18h with either virosomes (VIRO), lipo-
somes (LIPO) or controls (PBS, as shown). Expression of surfacemoleculemarkers HLA-DR,
CD40, CD80, CD86 was measured by flow cytometry. Figures show the receptor expression in
frequency of at least six independent experiments. Statistical significancewas determined by
ANOVA followed by Tukey’s HSD post hoc test to investigate individual paired comparisons.
(EPS)
S5 Fig. Expression of surfacemarkers and cytokines in MDDCs upon uptake of nanoparti-
cles in mono-culture.Cells were incubated for 18h with either virosomes (VIRO, with (4)
and without () Atto647), liposomes (LIPO, with (4) and without () Atto647) or controls
(PBS, as shown). Expression of surfacemoleculemarkers CD83, PD-L1, PD-L2, CCR7 and
intracellular cytokines IL-10 and IL-12 was measured by flow cytometry. Figures show the
receptor expression in frequency (A) and MFI (B) of at least six independent experiments. Sta-
tistical significancewas determined by ANOVA followed by Tukey’s HSD post hoc test to
investigate individual paired comparisons. p<0.05; p<0.01; p<0.001.
(EPS)
S6 Fig. Expression of cytokines in MDMs upon uptake of nanoparticles in mono-culture.
Cells were incubated for 18h with either virosomes (VIRO, with (4) and without () Atto647),
liposomes (LIPO, with (4) and without () Atto647) or controls (PBS, as shown). Expression
of intracellular cytokines IL-10 and IL-12 was measured by flow cytometry. Figures show
expression in frequency (A) and MFI (B) of at least six independent experiments. Statistical
significancewas determined by ANOVA followed by Tukey’s HSD post hoc test to investigate
individual paired comparisons. p<0.05; p<0.01; p<0.001.
(EPS)
S7 Fig. Expression of surfacemarkers and cytokines in MDDCs upon treatment with con-
trols in mono-culture.Cells were incubated for 18h with medium (DCs only), or positive con-
trols LPS and inactivated virus A/Brisbane/59/2007H1N1 (A/B). Expression of surface
moleculemarkers HLA-DR, CD40, CD80, CD86, CD83, PD-L1, PD-L2, CCR7 and intracellu-
lar cytokines IL-10 and IL-12 was measured by flow cytometry in MDDCs. Figures show
expression in frequency (A) and MFI (B) of at least six independent experiments. Statistical
significancewas determined by ANOVA followed by Tukey’s HSD post hoc test to investigate
individual paired comparisons. p<0.05; p<0.01; p<0.001.
(EPS)
S8 Fig. Expression of surfacemarkers and cytokines in MDMs upon treatment with con-
trols in mono-culture.Cells were incubated for 18h with medium (DCs only), or positive con-
trols LPS and inactivated influenza virus A/Brisbane/59/2007H1N1 (A/B). Expression of
surfacemoleculemarkers HLA-DR, CD40, CD80, CD86, CD163 and intracellular cytokines
IL-10 and IL-12 was measured by flow cytometry. Figures show the receptor expression in fre-
quency (A) and MFI (B) of at least six independent experiments. Statistical significancewas
determined by ANOVA followed by Tukey’s HSD post hoc test to investigate individual paired
comparisons. p<0.05; p<0.01; p<0.001.
(EPS)
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